In 2011, EQT acquired Atos Medical from Nordic Capital. The immature state of Atos Medical's key markets, with a significant organic growth potential and increasing penetration, was a key factor behind the investment.
Throughout its ownership, EQT supported management in implementing operational excellence across product sales and product innovation.
By 2016, Atos Medical was the global leader in the laryngectomy market, seven times as large as the second leading player, with 400 employees worldwide and a revenue exceeding SEK 1.0bn. The company has one of the largest dedicated ENT sales forces in the world, with offices in 18 markets and distributors serving more than 60 countries.